Joshua Kazam, Director at Kite Pharma Inc, holds 303.06K shares in Allogene Therapeutics (Ticker: ALLO), holds 94.48K shares in Kronos Bio (Ticker: KRON), holds 30.00K shares in Latch (Ticker: LTCH).
Joshua Kazam latest transaction was an Uninformative Buy of ―.
What was Joshua Kazam's most profitable transaction?
Joshua Kazam’s most profitable transaction was an Informative Buy of CAPR stock on January 22, 2015. The return on the trade was -42.30%.
What is Joshua Kazam's role in Kite Pharma Inc?
Joshua Kazam's role in Kite Pharma Inc is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.